Cambendazole

This classification denotes an antihelminthic agent with the molecular formula C14H14N4O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 079X63S3DU, chemically known as 5-benzimidazolecarbamic acid, 2-(4-thiazolyl)-, isopropyl ester but generally known as cambendazole, which bears US NIH Compound Identifier 33309. Cambendazole most often comes in base and methyl ester forms. European Medicines Agency schedules Cambendazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06062MIG. The term CAMBENDAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). CAMBENDAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cambendazole under HS 29341000 and SITC 51579. As of Q4 2014, CAMBENDAZOLE remains the US FDA Preferred Term for this commodity. Cambendazole bears US NLM identifiers UMLS ID C0006796 and NCI Concept Code C75212. SMILES: S1CC(NC1)C1[NH]C2C(N1)CCC(NC(=O)OC(C)C)C2.